94.55EUR-0.58%Mkt Cap: 26.14B $P/E: —1d ago
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also devel…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap26.14B $
Enterprise Value7.40B $
Revenue (TTM)2.88B $
Gross Profit2.42B $
Net Income (TTM)-1.23B $
Revenue/Share11.62 USD
Last Price94.55 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7.8K
CountryDE
SectorHealthcare
IndustryBiotechnology
ISINUS09075V1026
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.04
EV/EBITDA-4.93
EV/Revenue2.57
P/S8.72
P/B1.30
EPS (TTM)-6.71
EPS (Forward)—
52W Range
68.3070% of range105.70
52W High105.70 EUR
52W Low68.30 EUR
Profitability
Gross Margin77.64%
Oper. Margin-806.63%
EBITDA Margin-52.11%
Profit Margin-39.59%
ROE-5.91%
ROA-5.17%
Growth
Revenue Growth-59.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF495.65M $
CapEx (TTM)814.13M $
FCF Margin-9.42%
FCF Yield-1.04%
Net Debt-14.29B $
Net Debt/EBITDA9.52
Balance Sheet
Debt/Equity0.01
Current Ratio7.85
Quick Ratio7.03
Book Value/Sh70.69 EUR
Cash/Share53.60 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 2, 2022
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.251.20M
Float108.42M
Insiders57.51%
Institutions20.36%
Technical
SMA 5080.14 (+18.0%)
SMA 20083.49 (+13.3%)
Beta1.28
S&P 52W Chg20.26%
Avg Vol (30d)48.58K
Avg Vol (10d)20.12K
Technical Indicators
RSI (14)76.2
MACD2.0330
MACD Signal0.5829
MACD Hist.+1.4500
BB Upper91.02 EUR
BB Middle81.75 EUR
BB Lower72.48 EUR
BB Width22.67%
ATR (14)3.547 EUR
Vol Ratio (20d)3.47x